← Leaderboards
Joel Mark Kralj
Q-State Biosciences, Inc.
$2,484,500
Attributed
$2,659,000
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2014–16$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
Funding mix
By agency
NIH$2,659,000 · 2
By mechanism
DP2$2,310,000 · 1
R43$349,000 · 1
Top collaborators
- David Margulies1 shared
Most similar at Q-State Biosciences, Inc.
Same institution · by research overlap
- Christopher Werley$4,596,258
- Graham Thomas Dempsey$4,974,932
- Steven John Ryan$1,693,652
- James Fink$1,849,998
- Benjamin Nathaniel Harwood$1,451,257
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsDisease ModelNeuronsResearch StudyMeasurementElectrophysiology (Science)GeneticNeurodegenerative DisordersPharmacologic SubstanceSignal TransductionOpticsNeurosciencesCellsInstrumentCell TypeBiological Neural NetworksCell ModelCardiologyBeta CellAlzheimer&AposDevicesCustomDiabetes MellitusCardiac Myocytes